Entry Detail



General Information

Database ID:exR0261979
RNA Name:hsa-miR-31-5p
RNA Type:miRNA
Chromosome:chr9
Starnd:-
Coordinate:
Start Site(bp):21512158End Site(bp):21512178
External Links:hsa-miR-31-5p



Disease Information

Disease Name:Prostate Cancer
Disease Category:Cancers
MeSH ID:D011471
Type:Neoplasms/Digestive System Neoplasms
Alias:Prostatic Neoplasms//Prostate Neoplasms//Neoplasms, Prostate//Neoplasm, Prostate//Prostate Neoplasm//Neoplasms, Prostatic//Neoplasm, Prostatic//Prostatic Neoplasm//Prostate Cancer//Cancer, Prostate//Cancers, Prostate//Prostate Cancers//Cancer of the Prostate//Prostatic Cancer//Cancer, Prostatic//Cancers, Prostatic//Prostatic Cancers//Cancer of Prostate



Expression Detail

Created with Highcharts 7.0.1Expression value (z-scores)Chart context menuExpression boxplotCaseControl-0.45-0.4-0.35-0.3-0.25-0.2
GEO ID:GSE134266
Description:Deep sequencing identified serum extracellular vesicle delivered miR-181a-5p as an indicator for bone-metastatic prostate cancer (microarray)
Experimental Design:Cancer vs Control
Case Disease Type:Prostate Cancer
Case Disease SubType:Bone Metastatic Prostate Cancer
Case Sample:Bone Metastatic Prostate Cancer
Control Sample:Benign Prostatic Hyperplasia
Number of Case:8
Number of Control:9
Number of Samples:17





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABHD4
chr14
22598237
22613215
+
ANKRD52
chr12
56237807
56258384
-
BACH2
chr6
89926528
90296908
-
CHD1
chr5
98853985
98928957
-
CTNND1
chr11
57753243
57819546
+
FAM222B
chr17
28755978
28855232
-
FURIN
chr15
90868588
90883458
+
GRK2
chr11
67266473
67286556
+
HACD3
chr15
65530418
65578349
+
HOXA7
chr7
27153716
27157936
-
KIF3B
chr20
32277651
32335011
+
LONRF1
chr8
12721906
12756073
-
MAP3K14
chr17
45263119
45317029
-
PATL1
chr11
59636716
59669037
-
PLCB1
chr20
8077251
8968360
+
PPP1R3C
chr10
91628442
91633071
-
PRRC2B
chr9
131373636
131500197
+
RTL8B
chrX
135020513
135022542
-
RTL8C
chrX
135032355
135033546
+
SERF2
chr15
43777087
43802589
+
SMAD3
chr15
67063763
67195169
+
TRIM35
chr8
27284886
27311272
-
XPNPEP3
chr22
40857077
40932815
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0001728
chr7
99695763
99695845
-
hsa_circ_0001349
chr3
152132729
152150709
+
hsa_circ_0000241
chr10
70847874
70856944
+
hsa_circ_0000931
chr19
38226804
38231095
-
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004832.5
chr22
30420512
30420912
+
AC016876.2
chr17
7581964
7584086
-
AC074117.1
chr2
27356246
27367622
+
AC087477.2
chr15
96354237
96405235
+
GAS5
chr1
173858559
173868882
-
MAGI2-AS3
chr7
79452877
79471208
+
MIR497HG
chr17
7015818
7019659
-
NEAT1
chr11
65422774
65445540
+
SNHG16
chr17
76557764
76565348
+
TUG1
chr22
30969245
30979395
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE134266
Sample Source:Blood
Source Fraction:Extracellular Vesicle
Platform:GPL25134
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:2519
Sample treatment protocol:The blood was centrifuged at 2000 g for 10 min at 4 °C to extract the serum. The serum EV was extracted using Total Exosome Isolation Kit (from serum, Thermo fisher scientific).
RNA Extract protocol:Exosome Purification and RNA Isolation Kit (Norgen Biotek) was employed to purify EV and extract total RNA in EV consequentially.
RNA library preparation protocol:Sample tag and reagents are included in the hybrid need Agilent's micrornas Complete Labeling and Hyb Kit (p/n 5190-0456).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA



 
XIST